Impact of the Number of Opiates Prescribed on Post Cesarean Pain Control

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2017-06-16

Study Completion Date

2020-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this randomized trial is to examine whether the number of opioid pills prescribed for pain control after Cesarean section has an effect on patient reported pain levels and satisfaction with pain control during recovery. Both groups receive what is considered an adequate number of pills for pain control after an uncomplicated Cesarean delivery. Secondarily, the investigators wish to gather reliable information about the duration of use of opioids for pain control after uncomplicated Cesarean section, and what happens to unused medication.

After an uncomplicated Cesarean section, patients will be approached and asked to participate in the study. If the patient agrees, she will be randomly assigned to one of the two study groups and receive a prescription for opioid medication at the time of hospital discharge. At her standard care follow-up visit 10-14 days later, the participant will complete a survey asking questions about her pain levels during recovery, her use of study-related and non-study-related pain medication, and satisfaction with pain control. At that point the patient's participation in the study will end.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Satisfaction Following Cesarean Section

NCT03355248

Pain, Postoperative Cesarean Section Complications Postpartum Disorder +1 more

COMPLETED NA

Too Much of a Good Thing? Impact of Initial Prescription Size in Post-cesarean Section Pain Management

NCT05360433

Post Operative Pain

UNKNOWN PHASE4

To Compare the Efficacy and Patients' Satisfaction for the Treatment of Post Cesarean Pain of Two Protocols: Oral Medications in Fixed Time Interval Administration Versus Spinal Morphine

NCT02440399

Post Cesarean Pain Management

COMPLETED NA

Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications.

NCT06617949

Substance Use Disorder (SUD)

RECRUITING EARLY_PHASE1

Analgesia and Antihyperalgesia of Tramadol and Acetaminophen Per Oral After Caesarean Section

NCT00873743

Pain Cesarean Section

SUSPENDED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study Design and Methods:

The investigators will conduct a randomized controlled trial evaluating the difference in postpartum pain control in women receiving two different amounts of oxycodone after cesarean delivery.

Primary outcomes

• The primary outcome is the percent of patients who refill their narcotic prescription after cesarean delivery.

Secondary outcomes

1. Duration of use of narcotic after cesarean delivery, as assessed by the Post Cesarean Pain Control Survey (see attachment).
2. Amount of narcotic unused after cesarean delivery, measured in number of remaining pills, as assessed by the Post Cesarean Pain Control Survey.
3. Disposition of unused drug, as assessed by the Post Cesarean Pain Control Survey.
4. Patient satisfaction with pain control after cesarean delivery, as assessed by the Post Cesarean Pain Control Survey.

Patients will be identified by one of the investigators or designated research staff as either scheduled to undergo repeat cesarean delivery or status post cesarean from review of postpartum delivery lists. If they meet inclusion and exclusion criteria, they will be approached for enrollment in the study. If they consent they will be randomized on the day of discharge to group A or group B via sequentially numbered, sealed, opaque envelope. All patients will be provided standard education regarding pain control in the form of a fact sheet regarding trajectories of pain resolution, normative opioid consumption post cesarean, as well as risks, benefits and alternatives to opiates. If unable to purchase over the counter medications, prescriptions for ibuprofen and acetaminophen will be provided, as well as phone numbers for contact should any concerns arise between the time of discharge and post operative assessment. The patient will be scheduled for a postoperative wound check 10-14 days postpartum.

Postoperative wound evaluation will be performed in the research site's OB clinic setting at which time the survey will be completed by the patient regarding satisfaction with pain control, length of opiate treatment, number of opiates left in prescription and need for refills.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-operative Pain Control

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized Controlled Trial

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Participants and investigators will be aware of the arm to which they have been assigned.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm A - Oxycodone Pill A

Participants in this study arm will receive a prescription for a lower number oxycodone (oxycodone A) pills for post-cesarean pain control.

Group Type EXPERIMENTAL

Oxycodone Pill A

Intervention Type OTHER

Prescription for oxycodone pills for post-Cesarean delivery pain control after hospital discharge. Oxycodone is an opioid.

Arm B - Oxycodone Pill B

Participants in this study arm will receive a prescription for a higher number of oxycodone (oxycodone B) pills for post-cesarean pain control.

Group Type ACTIVE_COMPARATOR

Oxycodone Pill B

Intervention Type OTHER

Prescription for oxycodone pills for post-Cesarean delivery pain control after hospital discharge. Oxycodone is an opioid.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oxycodone Pill A

Prescription for oxycodone pills for post-Cesarean delivery pain control after hospital discharge. Oxycodone is an opioid.

Intervention Type OTHER

Oxycodone Pill B

Prescription for oxycodone pills for post-Cesarean delivery pain control after hospital discharge. Oxycodone is an opioid.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Oxycodone pill - lower number Oxycodone pill - higher number

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women 18-45 years
* English, Somali or Spanish Speaking
* Status post uncomplicated cesarean delivery performed at term (37w 0d to 42w 0d at time of delivery)
* Discharged at day 3 or 4 after cesarean section
* Willingness to participate in a survey 10-14 days post cesarean

Exclusion Criteria

* History of or current narcotic abuse
* History of chronic pain
* History or current opiate addiction
* Complicated cesarean delivery including cesarean hysterectomy, EBL \>1500 cc, bowel or bladder injury, postpartum infectious morbidity, postpartum wound break down
* Neonatal outcome requiring NICU admission for more than 48 hours

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No